These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9030492)

  • 1. Can the fast bone loss in osteoporotic and osteopenic patients be stopped with active vitamin D metabolites?
    Dambacher MA; Kranich M; Schacht E; Neff M
    Calcif Tissue Int; 1997 Jan; 60(1):115-8. PubMed ID: 9030492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly precise peripheral quantitative computed tomography for the evaluation of bone density, loss of bone density and structures. Consequences for prophylaxis and treatment.
    Dambacher MA; Neff M; Kissling R; Qin L
    Drugs Aging; 1998; 12 Suppl 1():15-24. PubMed ID: 9673862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micro-computed tomography and mechanical evaluation of trabecular bone structure in osteopenic and osteoporotic fractures.
    Ozan F; Pekedis M; Koyuncu Ş; Altay T; Yıldız H; Kayalı C
    J Orthop Surg (Hong Kong); 2017 Jan; 25(1):2309499017692718. PubMed ID: 28215116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Compliance of postmenopausal osteoporotic and osteopenic patients with calcium and vitamin D therapy].
    Akkaya N; Akkaya S; Yıldız N; Atalay NS; Sahin F
    Eklem Hastalik Cerrahisi; 2010 Dec; 21(3):130-5. PubMed ID: 21067493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Postmenopausal osteoporosis. Digital Rx radiogrammetry in the diagnosis and follow-up of treatment with alfacalcidol].
    Galeşanu C; Ciubotariu C; Melnic G; Galeşanu MR
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(4):833-41. PubMed ID: 17438884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation between global markers of bone formation and direct measurement of spinal bone formation in osteoporosis.
    Frost ML; Fogelman I; Blake GM; Marsden PK; Cook G
    J Bone Miner Res; 2004 Nov; 19(11):1797-804. PubMed ID: 15476579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 8. Vitamin D metabolites and analogs in the treatment of osteoporosis.
    Jones G; Hogan DB; Yendt E; Hanley DA
    CMAJ; 1996 Oct; 155(7):955-61. PubMed ID: 8837546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of osteoporosis risk and initiation of a nurse practitioner intervention program in an orthopedic practice.
    Seuffert P; Sagebien CA; McDonnell M; O'Hara DA
    Arch Osteoporos; 2016; 11():10. PubMed ID: 26847628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography.
    Boutroy S; Bouxsein ML; Munoz F; Delmas PD
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6508-15. PubMed ID: 16189253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale for active vitamin D and analogs in the treatment of osteoporosis.
    Nishii Y
    J Cell Biochem; 2003 Feb; 88(2):381-6. PubMed ID: 12520540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of bone loss in osteopenic patients with Crohn's disease: a double-blind, randomised trial of oral risedronate 35 mg once weekly or placebo, concomitant with calcium and vitamin D supplementation.
    van Bodegraven AA; Bravenboer N; Witte BI; Dijkstra G; van der Woude CJ; Stokkers PC; Russel MG; Oldenburg B; Pierik M; Roos JC; van Hogezand RA; Dik VK; Oostlander AE; Netelenbos JC; van de Langerijt L; Hommes DW; Lips P;
    Gut; 2014 Sep; 63(9):1424-30. PubMed ID: 24146170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular and molecular events associated with the bone-protecting activity of the noncalcemic vitamin D analog Ro-26-9228 in osteopenic rats.
    Peleg S; Uskokovic M; Ahene A; Vickery B; Avnur Z
    Endocrinology; 2002 May; 143(5):1625-36. PubMed ID: 11956143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemically administered rhBMP-2 promotes MSC activity and reverses bone and cartilage loss in osteopenic mice.
    Turgeman G; Zilberman Y; Zhou S; Kelly P; Moutsatsos IK; Kharode YP; Borella LE; Bex FJ; Komm BS; Bodine PV; Gazit D
    J Cell Biochem; 2002; 86(3):461-74. PubMed ID: 12210753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of anticonvulsant drug-induced bone disease.
    Drezner MK
    Epilepsy Behav; 2004 Feb; 5 Suppl 2():S41-7. PubMed ID: 15123011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Osteoporosis prevention initiated with peripheral quantitative computerized tomography. Thin-layer and multi-layer technique].
    Gass R; Neff M
    Praxis (Bern 1994); 1995 May; 84(18):521-5. PubMed ID: 7754270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new active vitamin D analog, ED-71, causes increase in bone mass with preferential effects on bone in osteoporotic patients.
    Kubodera N; Tsuji N; Uchiyama Y; Endo K
    J Cell Biochem; 2003 Feb; 88(2):286-9. PubMed ID: 12520528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D2 dose required to rapidly increase 25OHD levels in osteoporotic women.
    Mastaglia SR; Mautalen CA; Parisi MS; Oliveri B
    Eur J Clin Nutr; 2006 May; 60(5):681-7. PubMed ID: 16391587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of salmon calcitonin on trabecular microarchitecture as determined by magnetic resonance imaging: results from the QUEST study.
    Chesnut CH; Majumdar S; Newitt DC; Shields A; Van Pelt J; Laschansky E; Azria M; Kriegman A; Olson M; Eriksen EF; Mindeholm L
    J Bone Miner Res; 2005 Sep; 20(9):1548-61. PubMed ID: 16059627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of postmenopausal osteoporosis: how effective is transdermal hormone substitution? (Continuous estradiol plus sequential oral norethisterone acetate)].
    Gass R; Neff M
    Schweiz Med Wochenschr; 1995 Aug; 125(34):1583-91. PubMed ID: 7569830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a differential response to alfacalcidol and vitamin D in the treatment of osteoporosis?
    Francis RM
    Calcif Tissue Int; 1997 Jan; 60(1):111-4. PubMed ID: 9030491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.